Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 21.29%
March 31, 2026 14.05%
December 31, 2025 17.90%
September 30, 2025 29.29%
June 30, 2025 25.86%
March 31, 2025 16.89%
December 31, 2024 18.92%
September 30, 2024 14.12%
June 30, 2024 12.81%
March 31, 2024 8.08%
December 31, 2023 -166.0%
September 30, 2023 6.25%
June 30, 2023 -1.72%
March 31, 2023 2.56%
December 31, 2022 -80.82%
September 30, 2022 17.94%
June 30, 2022 23.79%
March 31, 2022 19.30%
December 31, 2021 20.05%
September 30, 2021 20.10%
June 30, 2021 16.14%
March 31, 2021 11.54%
December 31, 2020 9.73%
September 30, 2020 7.24%
June 30, 2020 5.37%
Date Value
March 31, 2020 8.49%
December 31, 2019 10.25%
September 30, 2019 9.95%
June 30, 2019 9.96%
March 31, 2019 11.79%
December 31, 2018 14.12%
September 30, 2018 18.03%
June 30, 2018 21.86%
March 31, 2018 19.21%
December 31, 2017 14.50%
September 30, 2017 8.86%
June 30, 2017 15.88%
March 31, 2017 17.54%
December 31, 2016 11.15%
September 30, 2016 13.13%
June 30, 2016 11.45%
March 31, 2016 12.99%
December 31, 2015 9.63%
September 30, 2015 11.91%
June 30, 2015 16.78%
March 31, 2015 17.31%
December 31, 2014 15.56%
September 30, 2014 17.17%
June 30, 2014 15.93%
March 31, 2014 12.19%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Olin Corp. 9.87%
Stepan Co. 14.61%
Solesence, Inc. 30.97%
BioLargo, Inc. 51.52%
The Chemours Co. 17.85%

Gross Profit Margin (Quarterly) Related Metrics